The kill-switch for CRISPR that could make gene-editing safer
Elie Dolgin • January 15, 2020
How anti-CRISPR proteins and other molecules could bolster biosecurity and improve medical treatments.
It started out as “sort of a stupid thing to do”, recalls Joe Bondy-Denomy, a microbiologist at the University of California, San Francisco.
Continue reading here.
With organoids, assembloids and a growing bioengineering toolkit, scientists are pushing the limits of human brain models.
Drug makers are scrambling to navigate an ‘existential threat’ to a once-celebrated technology.